Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.43 - $5.9 $7,095 - $97,350
-16,500 Reduced 1.86%
871,400 $504,000
Q2 2022

Aug 12, 2022

SELL
$0.38 - $0.64 $3,800 - $6,400
-10,000 Reduced 1.11%
887,900 $424,000
Q1 2022

May 16, 2022

SELL
$0.55 - $0.98 $2,090 - $3,724
-3,800 Reduced 0.42%
897,900 $602,000
Q4 2021

Feb 14, 2022

BUY
$0.9 - $1.31 $26,910 - $39,169
29,900 Added 3.43%
901,700 $889,000
Q3 2021

Nov 15, 2021

SELL
$1.21 - $1.61 $57,717 - $76,797
-47,700 Reduced 5.19%
871,800 $1.12 Million
Q2 2021

Aug 16, 2021

SELL
$1.6 - $2.02 $44,800 - $56,560
-28,000 Reduced 2.96%
919,500 $1.5 Million
Q1 2021

May 17, 2021

BUY
$1.86 - $2.87 $127,782 - $197,169
68,700 Added 7.82%
947,500 $1.88 Million
Q4 2020

Feb 16, 2021

BUY
$1.65 - $2.43 $59,400 - $87,480
36,000 Added 4.27%
878,800 $1.82 Million
Q3 2020

Nov 16, 2020

SELL
$1.6 - $2.35 $33,600 - $49,350
-21,000 Reduced 2.43%
842,800 $1.44 Million
Q2 2020

Aug 12, 2020

SELL
$1.33 - $2.76 $167,580 - $347,760
-126,000 Reduced 12.73%
863,800 $2 Million
Q1 2020

May 15, 2020

SELL
$0.97 - $2.85 $138,128 - $405,840
-142,400 Reduced 12.58%
989,800 $1.53 Million
Q4 2019

Jan 14, 2020

BUY
$1.69 - $3.8 $6,253 - $14,060
3,700 Added 0.33%
1,132,200 $4.3 Million
Q3 2019

Oct 31, 2019

BUY
$0.61 - $2.21 $17,252 - $62,503
28,282 Added 2.57%
1,128,500 $2.08 Million
Q2 2019

Jul 31, 2019

BUY
$0.51 - $0.86 $31,365 - $52,890
61,500 Added 5.92%
1,100,218 $717,000
Q1 2019

Apr 30, 2019

BUY
$0.51 - $0.82 $54,060 - $86,920
106,000 Added 11.36%
1,038,718 $650,000
Q4 2018

Feb 08, 2019

SELL
$0.48 - $1.1 $43,944 - $100,705
-91,550 Reduced 8.94%
932,718 $451,000
Q3 2018

Nov 13, 2018

SELL
$1.06 - $1.69 $142,358 - $226,967
-134,300 Reduced 11.59%
1,024,268 $1.13 Million
Q2 2018

Aug 13, 2018

SELL
$1.56 - $2.51 $315,822 - $508,149
-202,450 Reduced 14.87%
1,158,568 $1.81 Million
Q1 2018

May 14, 2018

BUY
$0.91 - $2.24 $131,991 - $324,903
145,046 Added 11.93%
1,361,018 $2.91 Million
Q4 2017

Feb 13, 2018

SELL
$0.78 - $2.1 $645,380 - $1.74 Million
-827,411 Reduced 40.49%
1,215,972 $1.12 Million
Q3 2017

Oct 30, 2017

BUY
$1.55 - $1.82 $3.17 Million - $3.72 Million
2,043,383
2,043,383 $3.62 Million

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $216M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.